Beijing's currency manipulation has prompted calls in Congress for protectionist legislation against China and other Asian nations. But commentator Adam Posen says lawmakers could hurt Americans with a response that's too broad.
The Senate's fragile bipartisan compromise on immigration is being tested by a series of proposed amendments, but the push and shove could come to an end soon. A vote may be forced as early as today, Jeremy Hobson reports.
The cast: British defense giant BAE, American banks, a Saudi Arabian prince. The alleged plotline: Contractor pays prince hundreds of millions to secure $80 billion defense deal. Now word that U.S. banks may be involved. Stephen Beard tells us how.
Employers in labor-intensive industries like agriculture are watching as Congress debates immigration reform. Changes in immigration laws could affect the food chain. Megan Larson reports.
Democrats are pressing ahead with spending bills that challenge President Bush to make good on his threat to veto ones that bust his budget. John Dimsdale reports on the likelihood of an ugly confrontation ahead.
Robert Reich says he's all for immigration, but he worries the immigration bill now pending in Congress is going to hurt qualified Americans looking for jobs, not to mention higher salaries.
A potential merger of the two top "natural" foods chains triggers anti-trust concerns, but they argue that traditional supermarkets are offering the same organic options. Ashley Milne-Tyte reports.
After enjoying years of unbridled growth, many homebuilders say they're now sinking along with the subprime lending market. So 1,300 of them are in Washington today to ask for help, and they have some unlikely allies, Steve Henn reports.
Congress holds a hearing today on the safety of diabetes drug Avandia. GlaxoSmithKline is mounting an aggressive defense for its No. 2 seller. With sales already plummeting, there's a lot of cash on the line. Helen Palmer reports
Fed chief Ben Bernanke said today he's still worried about inflation. Something else the Fed is keeping its eye on is the debt that some private equity firms are amassing in their recent buying binge. Amy Scott reports.
